Novo Nordisk
NVO
NVO
431 hedge funds and large institutions have $6.47B invested in Novo Nordisk in 2013 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 181 increasing their positions, 122 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
1% more funds holding
Funds holding: 425 → 431 (+6)
3% more capital invested
Capital invested by funds: $6.26B → $6.47B (+$210M)
1.17% less ownership
Funds ownership: 83.35% → 82.19% (-1.2%)
Holders
431
Holding in Top 10
16
Calls
$39M
Puts
$33M
Top Buyers
| 1 | +$57.6M | |
| 2 | +$44.7M | |
| 3 | +$30.2M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$29.3M |
| 5 |
Renaissance Technologies
New York
|
+$23.6M |
Top Sellers
| 1 | -$217M | |
| 2 | -$80.6M | |
| 3 | -$72.4M | |
| 4 |
O
OppenheimerFunds
New York
|
-$61.1M |
| 5 |
JPMorgan Chase & Co
New York
|
-$31.7M |